{
    "nct_id": "NCT06637423",
    "official_title": "A Phase 1/2 Open-label Clinical Study to Evaluate the Safety and Efficacy of Intravesical Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Participants With Intermediate-risk Nonmuscle Invasive Bladder Cancer (NMIBC)",
    "inclusion_criteria": "The key inclusion criteria include but are not limited to the following:\n\n* Has recurrent low-grade (Ta) Non-Muscle Invasive Bladder Cancer (NMIBC)\n* Must have visible tumor by cystoscopy within 12 weeks prior to first dose\n* Has intermediate-risk NMIBC defined as 1 or more of the following risk factors:\n\n  * Multiple tumors\n  * >1 occurrence of low-grade NMIBC within 1 year of the current diagnosis at Screening\n  * Early recurrence (<1 year) of the initial diagnosis of low-grade disease\n  * Solitary tumor >3 cm\n  * Failure of prior intravesical treatment\n* An Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 assessed within 14 days prior to first dose\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "The key exclusion criteria include but are not limited to the following:\n\n* Newly diagnosed low-grade nonmuscle invasive bladder cancer (Ta NMIBC)\n* Past or current history of high-grade (Ta or T1 or CIS) NMIBC, muscle invasive bladder cancer (MIBC) or metastatic urothelial carcinoma (UC)\n* Has a condition that would prohibit normal voiding (or hold bladder voiding for 1 to 2 hours)\n* Has history of documented severe dry eye syndrome, severe Meibomian gland disease, and/or blepharitis, or corneal disease that prevents and/or delays corneal healing\n* Has active inflammatory bowel disease requiring immunosuppressive medication or previous history of inflammatory bowel disease (eg, Chron's disease, ulcerative colitis, or chronic diarrhea)\n* Has uncontrolled, significant cardiovascular disease or cerebrovascular disease\n* Known additional malignancy that is progressing or has required active treatment within the past 3 years\n* History of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease.",
    "miscellaneous_criteria": ""
}